Rethinking Your Product Lifecycle Strategy in Medtech

As legacy PLM systems reach a critical transition point and vendor-driven changes force organizations to reevaluate their current platforms, medical device companies are facing a broader question: does their product development technology foundation support the speed, visibility, and control required today?

This session explores how medtech organizations are rethinking PLM as more than a standalone system, using it as a single source of truth that connects R&D, quality, and manufacturing. We'll examine how leading teams are streamlining the path from design and regulatory approval to production while leveraging simulation and AI to accelerate development and improve decision-making.

Attendees will learn:

• Why PLM disruption is driving a broader reassessment of product development technology foundations
• How PLM supports the transition from design and regulatory approval to controlled manufacturing  
• What it takes to establish a single source of truth across R&D, quality, and operations
• How simulation and AI can reduce iteration cycles and accelerate innovation